Cargando…
New insights into nanosystems for non-small-cell lung cancer: diagnosis and treatment
Lung cancer is caused by a malignant tumor that shows the fastest growth in both incidence and mortality and is also the greatest threat to human health and life. At present, both in terms of incidence and mortality, lung cancer is the first in male malignant tumors, and the second in female maligna...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300523/ https://www.ncbi.nlm.nih.gov/pubmed/37388143 http://dx.doi.org/10.1039/d3ra03099g |
_version_ | 1785064605524951040 |
---|---|
author | Jiang, Piao Liang, Bin Zhang, Zhen Fan, Bing Zeng, Lin Zhou, Zhiyong Mao, Zhifang Xu, Quan Yao, Weirong Shen, Qinglin |
author_facet | Jiang, Piao Liang, Bin Zhang, Zhen Fan, Bing Zeng, Lin Zhou, Zhiyong Mao, Zhifang Xu, Quan Yao, Weirong Shen, Qinglin |
author_sort | Jiang, Piao |
collection | PubMed |
description | Lung cancer is caused by a malignant tumor that shows the fastest growth in both incidence and mortality and is also the greatest threat to human health and life. At present, both in terms of incidence and mortality, lung cancer is the first in male malignant tumors, and the second in female malignant tumors. In the past two decades, research and development of antitumor drugs worldwide have been booming, and a large number of innovative drugs have entered clinical trials and practice. In the era of precision medicine, the concept and strategy of cancer from diagnosis to treatment are experiencing unprecedented changes. The ability of tumor diagnosis and treatment has rapidly improved, the discovery rate and cure rate of early tumors have greatly improved, and the overall survival of patients has benefited significantly, with a tendency to transform to a chronic disease with tumor. The emergence of nanotechnology brings new horizons for tumor diagnosis and treatment. Nanomaterials with good biocompatibility have played an important role in tumor imaging, diagnosis, drug delivery, controlled drug release, etc. This article mainly reviews the advancements in lipid-based nanosystems, polymer-based nanosystems, and inorganic nanosystems in the diagnosis and treatment of non-small-cell lung cancer (NSCLC). |
format | Online Article Text |
id | pubmed-10300523 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The Royal Society of Chemistry |
record_format | MEDLINE/PubMed |
spelling | pubmed-103005232023-06-29 New insights into nanosystems for non-small-cell lung cancer: diagnosis and treatment Jiang, Piao Liang, Bin Zhang, Zhen Fan, Bing Zeng, Lin Zhou, Zhiyong Mao, Zhifang Xu, Quan Yao, Weirong Shen, Qinglin RSC Adv Chemistry Lung cancer is caused by a malignant tumor that shows the fastest growth in both incidence and mortality and is also the greatest threat to human health and life. At present, both in terms of incidence and mortality, lung cancer is the first in male malignant tumors, and the second in female malignant tumors. In the past two decades, research and development of antitumor drugs worldwide have been booming, and a large number of innovative drugs have entered clinical trials and practice. In the era of precision medicine, the concept and strategy of cancer from diagnosis to treatment are experiencing unprecedented changes. The ability of tumor diagnosis and treatment has rapidly improved, the discovery rate and cure rate of early tumors have greatly improved, and the overall survival of patients has benefited significantly, with a tendency to transform to a chronic disease with tumor. The emergence of nanotechnology brings new horizons for tumor diagnosis and treatment. Nanomaterials with good biocompatibility have played an important role in tumor imaging, diagnosis, drug delivery, controlled drug release, etc. This article mainly reviews the advancements in lipid-based nanosystems, polymer-based nanosystems, and inorganic nanosystems in the diagnosis and treatment of non-small-cell lung cancer (NSCLC). The Royal Society of Chemistry 2023-06-28 /pmc/articles/PMC10300523/ /pubmed/37388143 http://dx.doi.org/10.1039/d3ra03099g Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by-nc/3.0/ |
spellingShingle | Chemistry Jiang, Piao Liang, Bin Zhang, Zhen Fan, Bing Zeng, Lin Zhou, Zhiyong Mao, Zhifang Xu, Quan Yao, Weirong Shen, Qinglin New insights into nanosystems for non-small-cell lung cancer: diagnosis and treatment |
title | New insights into nanosystems for non-small-cell lung cancer: diagnosis and treatment |
title_full | New insights into nanosystems for non-small-cell lung cancer: diagnosis and treatment |
title_fullStr | New insights into nanosystems for non-small-cell lung cancer: diagnosis and treatment |
title_full_unstemmed | New insights into nanosystems for non-small-cell lung cancer: diagnosis and treatment |
title_short | New insights into nanosystems for non-small-cell lung cancer: diagnosis and treatment |
title_sort | new insights into nanosystems for non-small-cell lung cancer: diagnosis and treatment |
topic | Chemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300523/ https://www.ncbi.nlm.nih.gov/pubmed/37388143 http://dx.doi.org/10.1039/d3ra03099g |
work_keys_str_mv | AT jiangpiao newinsightsintonanosystemsfornonsmallcelllungcancerdiagnosisandtreatment AT liangbin newinsightsintonanosystemsfornonsmallcelllungcancerdiagnosisandtreatment AT zhangzhen newinsightsintonanosystemsfornonsmallcelllungcancerdiagnosisandtreatment AT fanbing newinsightsintonanosystemsfornonsmallcelllungcancerdiagnosisandtreatment AT zenglin newinsightsintonanosystemsfornonsmallcelllungcancerdiagnosisandtreatment AT zhouzhiyong newinsightsintonanosystemsfornonsmallcelllungcancerdiagnosisandtreatment AT maozhifang newinsightsintonanosystemsfornonsmallcelllungcancerdiagnosisandtreatment AT xuquan newinsightsintonanosystemsfornonsmallcelllungcancerdiagnosisandtreatment AT yaoweirong newinsightsintonanosystemsfornonsmallcelllungcancerdiagnosisandtreatment AT shenqinglin newinsightsintonanosystemsfornonsmallcelllungcancerdiagnosisandtreatment |